BS3 Pharmaceutical Storage & Logistics announces the commissioning of its latest state-of-the-art vault facility, significantly increasing high-security, temperature-controlled storage capacity. This milestone directly addresses the rising demand for GWP-compliant storage solutions for Schedules 2, 3, 4, 8, and 9 pharmaceutical products across Australia’s healthcare and life sciences sector.
The expansion reinforces BS3’s position as a trusted leader in pharmaceutical storage and logistics, marking our third consecutive year of strategic facility growth.
Purpose-built with advanced temperature controlled storage, incorporating new AI security features, the new vault provides increased capacity for high-value, tightly regulated products from clinical trial materials to commercial stock.
“The commissioning of this new vault is a direct response to the growing trust our clients place in us and the evolving needs of the Australian pharmaceutical industry,” said Managing Director Andrew Gibson. “It demonstrates our commitment to investing in infrastructure that ensures seamless continuity, uncompromising compliance, and the most secure storage solutions available.”
BS3 continues to set the benchmark for precision, compliance, and scalability in pharmaceutical storage and logistics.
To discuss your Schedule 2, 3, 4, 8, or 9 pharmaceutical storage and distribution needs, be sure to contact us today.
Ready to protect your product? Let’s talk.
📞 (03) 7036 0065
📧 contact@bs3.com.au
🌐 bs3.com.au
